In a world of microservices development and Docker-based deployments, RESTful web services tend to grab all the headlines. However, there's still a place in modern enterprise architectures for ...
The FDA has rejected a biologics license application for apitegromab to treat spinal muscular atrophy, according to manufacturer Scholar Rock.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback